• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个有关尾巴的故事:唾液酸酶是噬菌体治疗 K1 荚膜大肠杆菌模型中成功的关键。

A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli.

机构信息

Section of Integrative Biology, The University of Texas at Austin, Austin, TX 78712, USA.

出版信息

Virology. 2010 Mar 1;398(1):79-86. doi: 10.1016/j.virol.2009.11.040. Epub 2009 Dec 16.

DOI:10.1016/j.virol.2009.11.040
PMID:20006993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2843586/
Abstract

Prior studies treating mice infected with Escherichia coli O18:K1:H7 observed that phages requiring the K1 capsule for infection (K1-dep) were superior to capsule-independent (K1-ind) phages. We show that three K1-ind phages all have low fitness when grown on cells in serum whereas fitnesses of four K1-dep phages were high. The difference is serum-specific, as fitnesses in broth overlapped. Sialidase activity was associated with all K1-dep virions tested but no K1-ind virions, a phenotype supported by sequence analyses. Adding endosialidase to cells infected with K1-ind phage increased fitness in serum by enhancing productive infection after adsorption. We propose that virion sialidase activity is the primary determinant of high fitness on cells grown in serum, and thus in a mammalian host. Although the benefit of sialidase is specific to K1-capsulated bacteria, this study may provide a scientific rationale for selecting phages for therapeutic use in many systemic infections.

摘要

先前研究感染大肠杆菌 O18:K1:H7 的小鼠时发现,需要 K1 荚膜才能感染的噬菌体(K1 依赖型噬菌体)比不依赖荚膜的噬菌体(K1 独立型噬菌体)更优越。我们发现,当在含血清的细胞中生长时,三种 K1 独立型噬菌体的适应性都较低,而四种 K1 依赖型噬菌体的适应性都较高。这种差异是血清特异性的,因为在肉汤中的适应性重叠。唾液酸酶活性与所有测试的 K1 依赖型病毒粒子都有关,但与 K1 独立型病毒粒子无关,这一表型得到了序列分析的支持。向感染 K1 独立型噬菌体的细胞中添加内切唾液酸酶,通过增强吸附后的有效感染,提高了在血清中的适应性。我们提出,病毒粒子的唾液酸酶活性是在含血清的细胞中适应性高的主要决定因素,因此也是在哺乳动物宿主中适应性高的主要决定因素。尽管唾液酸酶的益处是特定于 K1 荚膜细菌的,但这项研究可能为选择噬菌体用于治疗许多全身性感染提供了科学依据。

相似文献

1
A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli.一个有关尾巴的故事:唾液酸酶是噬菌体治疗 K1 荚膜大肠杆菌模型中成功的关键。
Virology. 2010 Mar 1;398(1):79-86. doi: 10.1016/j.virol.2009.11.040. Epub 2009 Dec 16.
2
In vivo growth rates are poorly correlated with phage therapy success in a mouse infection model.在小鼠感染模型中,噬菌体治疗的成功率与噬菌体的体内生长速率相关性较差。
Antimicrob Agents Chemother. 2012 Feb;56(2):949-54. doi: 10.1128/AAC.05842-11. Epub 2011 Nov 21.
3
Evolution of bacteriophages infecting encapsulated bacteria: lessons from Escherichia coli K1-specific phages.感染荚膜细菌的噬菌体的进化:来自大肠杆菌K1特异性噬菌体的经验教训。
Mol Microbiol. 2006 Jun;60(5):1123-35. doi: 10.1111/j.1365-2958.2006.05173.x.
4
Bacteriophage K1-5 encodes two different tail fiber proteins, allowing it to infect and replicate on both K1 and K5 strains of Escherichia coli.噬菌体K1-5编码两种不同的尾丝蛋白,使其能够在大肠杆菌的K1和K5菌株上感染和复制。
J Virol. 2001 Mar;75(6):2509-15. doi: 10.1128/JVI.75.6.2509-2515.2001.
5
The genome of bacteriophage K1F, a T7-like phage that has acquired the ability to replicate on K1 strains of Escherichia coli.噬菌体K1F的基因组,它是一种类似T7的噬菌体,已获得在大肠杆菌K1菌株上复制的能力。
J Bacteriol. 2005 Dec;187(24):8499-503. doi: 10.1128/JB.187.24.8499-8503.2005.
6
Novel Host Recognition Mechanism of the K1 Capsule-Specific Phage of : Capsular Polysaccharide as the First Receptor and Lipopolysaccharide as the Secondary Receptor.荚膜 K1 特异性噬菌体的新型宿主识别机制:荚膜多糖作为第一受体和脂多糖作为第二受体。
J Virol. 2021 Aug 25;95(18):e0092021. doi: 10.1128/JVI.00920-21.
7
Escherichia coli K1's capsule is a barrier to bacteriophage T7.大肠杆菌K1的荚膜是噬菌体T7的一道屏障。
Appl Environ Microbiol. 2005 Aug;71(8):4872-4. doi: 10.1128/AEM.71.8.4872-4874.2005.
8
Structure and biochemical characterization of bacteriophage phi92 endosialidase.噬菌体phi92唾液酸内切酶的结构与生化特性
Virology. 2015 Mar;477:133-143. doi: 10.1016/j.virol.2014.11.002. Epub 2014 Dec 1.
9
Escherichia coli K1-specific bacteriophage CUS-3 distribution and function in phase-variable capsular polysialic acid O acetylation.大肠杆菌K1特异性噬菌体CUS-3在相变荚膜多聚唾液酸O-乙酰化中的分布与功能
J Bacteriol. 2007 Sep;189(17):6447-56. doi: 10.1128/JB.00657-07. Epub 2007 Jun 29.
10
K1 capsule-dependent phage-driven evolution in Escherichia coli leading to phage resistance and biofilm production.K1 胶囊依赖性噬菌体驱动的大肠杆菌进化导致噬菌体抗性和生物膜产生。
J Appl Microbiol. 2024 May 1;135(5). doi: 10.1093/jambio/lxae109.

引用本文的文献

1
A VersaTile Approach to Reprogram the Specificity of the R2-Type Tailocin Towards Different Serotypes of and .一种灵活的方法来重新编程R2型尾菌素针对不同血清型的特异性。 (原文中“and.”表述不完整,可能影响准确理解)
Antibiotics (Basel). 2025 Jan 18;14(1):104. doi: 10.3390/antibiotics14010104.
2
Therapeutic and Diagnostic Potential of a Novel K1 Capsule Dependent Phage, JSSK01, and Its Depolymerase in Multidrug-Resistant Infections.新型K1荚膜依赖性噬菌体JSSK01及其解聚酶在多重耐药感染中的治疗和诊断潜力
Int J Mol Sci. 2024 Nov 21;25(23):12497. doi: 10.3390/ijms252312497.
3
Phage-Mediated Digestive Decolonization in a Gut-On-A-Chip Model: A Tale of Gut-Specific Bacterial Prosperity.噬菌体介导的肠道芯片模型中的消化去定植:一个关于肠道特异性细菌繁荣的故事。
Viruses. 2024 Jun 28;16(7):1047. doi: 10.3390/v16071047.
4
Schlesinger Nailed It! Assessing a Key Primary Pharmacodynamic Property of Phages for Phage Therapy: Virion Encounter Rates with Motionless Bacterial Targets.施莱辛格做到了!评估噬菌体疗法中噬菌体的一项关键主要药效学特性:静止细菌靶点的病毒体相遇率。
Drugs Drug Candidates. 2023 Sep;2(3):673-688. doi: 10.3390/ddc2030034. Epub 2023 Aug 18.
5
Antibacterial effects of single phage and phage cocktail against multidrug-resistant Klebsiella pneumoniae isolated from diabetic foot ulcer.噬菌体单剂和鸡尾酒对糖尿病足溃疡分离的多重耐药肺炎克雷伯菌的抗菌作用。
Virus Genes. 2023 Aug;59(4):635-642. doi: 10.1007/s11262-023-02004-z. Epub 2023 May 31.
6
Comparative Genomics of a Polyvalent Phage fp01 and In Silico Analysis of Its Receptor Binding Protein and Conserved Enterobacteriaceae Phage Receptor.多价噬菌体 fp01 的比较基因组学及其受体结合蛋白和保守肠杆菌噬菌体受体的计算机分析。
Viruses. 2023 Jan 28;15(2):379. doi: 10.3390/v15020379.
7
The Antibacterial Effects of Cocktail and Single Forms of Lytic Phages Belonging to and Families from Sewage against and .鸡尾酒形式和单一形式的裂解噬菌体对 和 的抗菌作用,这些噬菌体属于 和 科,来自污水。
Biomed Res Int. 2022 Nov 25;2022:7833565. doi: 10.1155/2022/7833565. eCollection 2022.
8
Analysis of the anaerobic digestion metagenome under environmental stresses stimulating prophage induction.分析环境胁迫下刺激噬菌体诱导的厌氧消化元基因组。
Microbiome. 2022 Aug 15;10(1):125. doi: 10.1186/s40168-022-01316-w.
9
In Vitro Characterization and In Vivo Efficacy Assessment in Larvae of Newly Isolated Bacteriophages against K1.新型噬菌体对 K1 的体外鉴定及其在幼虫体内的功效评估
Viruses. 2021 Oct 6;13(10):2005. doi: 10.3390/v13102005.
10
Overcoming the growth-infectivity trade-off in a bacteriophage slows bacterial resistance evolution.克服噬菌体生长与感染性之间的权衡可减缓细菌耐药性的演变。
Evol Appl. 2021 Jun 19;14(8):2055-2063. doi: 10.1111/eva.13260. eCollection 2021 Aug.

本文引用的文献

1
In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli.T4和T7噬菌体在定殖有大肠杆菌的无菌小鼠体内的复制
Virology. 2009 Oct 10;393(1):16-23. doi: 10.1016/j.virol.2009.07.020. Epub 2009 Aug 21.
2
T4 phages against Escherichia coli diarrhea: potential and problems.针对大肠杆菌性腹泻的T4噬菌体:潜力与问题
Virology. 2009 May 25;388(1):21-30. doi: 10.1016/j.virol.2009.03.009. Epub 2009 Apr 1.
3
Characterization of bacteriophages used in the Salmonella enterica serovar Enteritidis phage-typing scheme.用于肠炎沙门氏菌肠炎血清型噬菌体分型方案的噬菌体特性分析。
J Med Microbiol. 2009 Jan;58(Pt 1):86-93. doi: 10.1099/jmm.0.000034-0.
4
Bacteriophage therapy--cooked goose or phoenix rising?噬菌体疗法——煮熟的鹅还是浴火重生的凤凰?
Curr Opin Biotechnol. 2008 Dec;19(6):608-12. doi: 10.1016/j.copbio.2008.09.001. Epub 2008 Nov 5.
5
Crystal structure of Escherichia coli phage HK620 tailspike: podoviral tailspike endoglycosidase modules are evolutionarily related.大肠杆菌噬菌体HK620尾刺的晶体结构:肌尾噬菌体尾刺内切糖苷酶模块具有进化相关性。
Mol Microbiol. 2008 Jul;69(2):303-16. doi: 10.1111/j.1365-2958.2008.06311.x.
6
Biosynthesis of the Escherichia coli K1 group 2 polysialic acid capsule occurs within a protected cytoplasmic compartment.大肠杆菌K1组2型聚唾液酸荚膜的生物合成发生在一个受保护的细胞质区室中。
Mol Microbiol. 2008 Jun;68(5):1252-67. doi: 10.1111/j.1365-2958.2008.06231.x. Epub 2008 Apr 8.
7
Evolution of a new enzyme activity from the same motif fold.同一基序折叠产生新酶活性的进化过程。
Mol Microbiol. 2008 Jul;69(2):287-90. doi: 10.1111/j.1365-2958.2008.06241.x.
8
Predicting evolution from genomics: experimental evolution of bacteriophage T7.从基因组学预测进化:噬菌体T7的实验进化
Heredity (Edinb). 2008 May;100(5):453-63. doi: 10.1038/sj.hdy.6801087. Epub 2008 Jan 23.
9
Novel approaches to developing new antibiotics for bacterial infections.开发用于治疗细菌感染的新型抗生素的新方法。
Br J Pharmacol. 2007 Dec;152(8):1147-54. doi: 10.1038/sj.bjp.0707432. Epub 2007 Aug 20.
10
Testing optimality with experimental evolution: lysis time in a bacteriophage.通过实验进化测试最优性:噬菌体的裂解时间
Evolution. 2007 Jul;61(7):1695-709. doi: 10.1111/j.1558-5646.2007.00132.x.